No connection

Search Results

AVNT

NEUTRAL
$37.4 Live
Avient Corporation · NYSE
Target $41.75 (+11.6%)
$27.48 52W Range $44.78

At a glance

Key valuation, profitability, growth, and risk metrics.

Unlock key metrics

Market cap, P/E, ROE, margins, leverage and more.

AI Analysis

AI-powered fundamental assessment

Confidence
65%
Avient Corporation exhibits a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score to confirm safety from distress. While profitability metrics and recent earnings surprises are positive, declining revenue and earnings growth, coupled with a high payout ratio and elevated valuation, constrain long-term appeal. The stock trades above both the Graham Number ($26.67) and intrinsic value estimate ($8.54), suggesting overvaluation on defensive and growth criteria. However, strong short-term price momentum and analyst consensus of 'strong_buy' provide counterbalancing support.

Key Strengths

Consistent quarterly earnings beats with 3 out of last 4 quarters exceeding estimates and a strong average surprise of 1.25%
Solid gross margin of 31.92%, indicating pricing power and cost control in specialty chemicals segment
Current ratio of 2.03 and quick ratio of 1.33 reflect adequate short-term liquidity
Dividend yield of 292% provides income appeal relative to sector average
Recent price momentum is strong, with +19.3% 1-month return and +11.9% over 6 months

Key Risks

Piotroski F-Score of 4/9 indicates weak financial health, particularly concerning profitability and leverage trends
Negative year-over-year revenue growth (-1.10%) and declining earnings (-13.20%) signal fundamental weakness
High payout ratio of 87.80% threatens dividend sustainability given earnings volatility
Forward P/E of 12.26 is reasonable, but current P/E of 30.66 is elevated relative to earnings trajectory
Lack of Altman Z-Score prevents confirmation of financial distress risk, creating uncertainty
AI Fair Value Estimate
Based on comprehensive analysis
$26.67
-28.7% below current price

Performance Snowflake

Multi-dimensional AI analysis across 5 key categories

Unlock AI-Powered Analysis

See Value, Future Performance, Past Performance, Financial Health & Dividend scores

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Unlock Price Charts

View historical price trends and analyst targets

Historical Performance Trends

Long-term financial metrics and growth patterns

Unlock Historical Data

View 3-year revenue, profit margins, and growth trends

Valuation Metrics

Key valuation ratios and pricing indicators

Sign up to view

P/E, P/B, P/S, EV/EBITDA and more

Profitability, Growth & Financial Health

Detailed profit margins, ROE, debt ratios, and liquidity metrics

Unlock Detailed Metrics

View ROE, Operating Margin, Debt/Equity, Current Ratio and more

Sector Comparison & Peer Analysis

Compare AVNT against industry averages and similar companies

Unlock Sector Insights

See how AVNT compares to competitors and industry standards

Insider Trading & Analyst Ratings

Track insider transactions and Wall Street analyst recommendations

Unlock Insider Data

See recent insider buys/sells and analyst price targets

Past News Coverage

Recent headlines mentioning AVNT from our newsroom.

Newest → oldest

See the full AVNT analysis

Free signup • Unlock all metrics • No credit card required

TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile